Issuances of Common Shares and Warrants (Detail Narrative) - USD ($) |
1 Months Ended | 3 Months Ended | 9 Months Ended | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mar. 02, 2024 |
Oct. 03, 2023 |
May 11, 2023 |
Apr. 30, 2024 |
Apr. 26, 2024 |
Feb. 16, 2024 |
Oct. 26, 2023 |
May 31, 2024 |
Nov. 30, 2023 |
May 31, 2023 |
Nov. 30, 2022 |
May 31, 2024 |
May 31, 2023 |
|
| Term | 1 year 1 month 6 days | ||||||||||||
| Stock based compensation | $ 341,773 | $ 53,953 | $ 81,446 | $ 68,776 | $ 395,726 | $ 160,748 | |||||||
| Unrecognized non-cash compensation costs | $ 302,474 | ||||||||||||
| Non-vested stock options | 150,000 | ||||||||||||
| Option strike price | $ 2.93 | ||||||||||||
| Weighted average remaining contractual life | 1 year 5 months 12 days | ||||||||||||
| Chief Financial Officer [Member] | |||||||||||||
| Granted options | 200,000 | ||||||||||||
| Exercise price, option | $ 2.93 | ||||||||||||
| Term | 5 years | ||||||||||||
| Officers And Employees Additional [Member] | |||||||||||||
| Granted options | 85,000 | ||||||||||||
| Exercise price, option | $ 1.15 | ||||||||||||
| Term | 5 years | ||||||||||||
| Officers And Employees [Member] | |||||||||||||
| Granted options | 151,500 | ||||||||||||
| Exercise price, option | $ 2.36 | ||||||||||||
| Term | 5 years | ||||||||||||
| Securities Purchase Agreement [Member] | |||||||||||||
| Proceeds from issuance of common stock | $ 1,569,780 | $ 1,541,137 | $ 2,837,664 | ||||||||||
| Stock issued during period, shares | $ 1,618,330 | $ 1,622,250 | $ 1,298,702 | ||||||||||
| Common shares to be purchase | 1,444,741 | 1,558,443 | |||||||||||
| Purchase of Pre-funded warrants | 113,702 | ||||||||||||
| Offering price | $ 2.31 | ||||||||||||
| Exercise price | $ 0.97 | $ 0.95 | $ 2.185 | $ 2.185 | |||||||||
| Equity Incentive Plan [Member] | |||||||||||||
| Description of incentives plan | Company has established an Equity Incentive Plan which was most recently amended by the Company’s shareholders on May 9, 2023. Pursuant to the amendments which were affected on January 18, 2024 when the Company filed a Form S-8 Registration Statement, the Equity Incentive Plan now has an evergreen formula, whereby on January 1 each year commencing January 1, 2024, the number of shares issuable pursuant to the Equity Incentive Plan may be increased to a number equal to up to 10% of the issued share capital on December 31 of the previous year | ||||||||||||
| Aggregate common shares issuable | 1,037,544 | ||||||||||||
| Additional shares to be issued | 527,111 | ||||||||||||
| Placement Agent [Member] | |||||||||||||
| Proceeds to direct offering | $ 3,000,000 | ||||||||||||
| Common shares to be purchase | 54,546 | ||||||||||||
| Exercise price | $ 2.8875 | ||||||||||||
| Securities Purchase Agreement Other [Member] | |||||||||||||
| Proceeds from issuance of common stock | $ 4,407,444 | $ 73 | |||||||||||
| Proceed from issuance of common stock additional | 364,629 | ||||||||||||
| Placement agent fees and other offering expenses | $ 209,796 | ||||||||||||
| Common shares to be purchase | 1,618,330 | ||||||||||||
| Purchase of Pre-funded warrants | 729,058 | ||||||||||||
| Offering price | $ 0.97 | ||||||||||||
| Exercise price | $ 5.9375 | $ 0.97 | |||||||||||
| Purchase of common stock | 2,917,032 | 889,272 | |||||||||||
| Net proceeds | $ 1,250,000 | ||||||||||||
| New unregistered purchase of common stock | 2,917,032 | ||||||||||||
| New unregistered purchase of common stock consideration price | $ 0.125 | ||||||||||||
| Securities Purchase Agreement Two [Member] | |||||||||||||
| Proceeds from issuance of common stock | $ 73 | $ 11 | |||||||||||
| Exercise price | $ 0.0001 | $ 0.0001 | |||||||||||
| Common shares pre-funded warrants issued | 729,058 | 113,702 | |||||||||||